Intern Physician ๐ฎ๐ณ
Fellow of College of the European School of Oncology (ESO) @ESOncology
ESMO Travel Grant Recipient (@myESMO-@NCCS_SG-@dukenus Scholar)
Is the world on track to meet WHOโs Global Oral Health Action Plan to achieve a 10% relative reduction in the combined prevalence of main oral conditions by 2030? Authors of a recent study estimated that the pace of progress is lacking: https://t.co/z6Cqx06Lxh
Honored to be recognized as a #Fellow of College of the European School of Oncology (ESCO)๐!
This milestone represents my engagement with the college, extracurricular activities, and scientific contributions to oncology.
Thank you @ESOncology โค๏ธ
Grateful to be a part of @ESOncology@ESSOnews@ESP_Pathology@ESTRO_RT Multidisciplinary Course for Medical Students @jkulinz.
Earned the title of Student of College of the European School of Oncology (ESCO).
Welcome to @ESOncology@ESTRO_RT@ESP_Pathology and @ESSOnews jointly organised course!
๐This week, our goal is to encourage medical students to specialize in an oncology related discipline.
Progress toward reducing oral conditions varied across geographic locations from 2019 to 2023, according to new IHME research published in @TheLancetPH โ https://t.co/k91vlfMqvO
According to new research published today in @TheLancetPH, age-standardized prevalence of main oral conditions declined worldwide between 2019 and 2023. However, global cases increased by 3.07%, from 3.62 billion to 3.73 billion.
Read the study: https://t.co/fMqgnKKkac
Got accepted for @myESMO-@NCCS_SG-@dukenus Course in Medical Oncology 2026.
Thanks a lot to the selection committee for identifying my efforts and honoring it.
Selected for @ESOncology@ESP_Pathology@ESSOnews@ESTRO_RT Multidisciplinary Program for Medical Students.
Happy to be among the selected 40 students Globally.
A bow to my mentors: Dr. R. S. Arora, Dr. A. Ghose, Prof. S. Boussios.
Abstract Published @ASCO@JCO_ASCO
2026 Annual Meeting
Title: Artificial intelligence vs human-based frameworks for breast cancer molecular biomarker status assessment: A benchmarking analysis from 2500 patients.
Link: https://t.co/7ZzmAeET91
Same article, cited again, in a week.
It was cited in an article published in 'Lung Cancer', an @myESMO Journal.
Looking forward to submitting more articles to the Journal of Oncology Pharmacy Practice @ISOPPorg@SageJournals
https://t.co/SWtrvGBebt
First Citation ๐ฅ
JOPP (@ISOPPorg)
Title:
Efficacy and safety of ensartinib in the treatment of non-small cell lung cancer: A systematic review of clinical trials
Author: Trushdeep Agrawal
Give it a read: https://t.co/QWpZYuyQ2B
(Connect with me if you need a full text link.)
Our article was published in the CDP Journal @IIAR_Journals
Genetically Optimized Modular Neural Networks for Precision Lung Cancer Diagnosis: Exploratory Study of Novel Approach
Authors: V L Agrawal, T Agrawal, A Ghose, S Adeleke, S Boussios, R S Arora https://t.co/LW2DVsfbQM
I am now officially a GBD Collaborator.
Looking forward to making a meaningful impact in Global Burden of Disease Studies, and Data-Driven Policy Making and Advocacy at Institute for Health Metrics and Evaluation & University of Washington (@IHME_UW & @UW)